Trial intelligence / Profile preview

Amnesic Properties of Propofol in Pediatric Patients

NCT02278003Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Feb 2012
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of propofol in Procedural sedation (PS) (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Sedation Threshold at 1 year. Started Feb 2012; status: completed.

02

Drugs

propofol
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT02278003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02278003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call